Youjia Biopharma Achieves Triple Leap in Xiaoshan’s '5213' Program, Named Industrialization Pacesetter
YOUJIA BIO
Nucleic Acid Drug Developer
Recently, the evaluation results of the first batch of innovation and entrepreneurship teams in Xiaoshan District, Hangzhou City in 2026, the "5213" project, were announced. The nucleic acid drug development platform industrialization and multi-pipeline development project based on the NOX1 target, declared by Youjia (Hangzhou) Biomedical Technology Co., Ltd. (27th on the announcement list), was successfully selected and rated.Industrial Leadership CategoryProject.
Public Notice of the Evaluation Results for the First Batch of Xiaoshan District Innovation and Entrepreneurship Teams "5213" Project in 2026
This is since YOUJIA BIO's establishment in Xiaoshan in 2020 under the "5213" policy, followingEmerging Startup Category、Start-up Navigation CategoryThereafter, it once again achieved a hierarchical leap and completedFrom Initial Incubation to Industrial Leadership: A Triple Jump, marking that the company's technical strength, R&D progress, and industrialization capabilities have gained authoritative recognition in Xiaoshan District.
Since its establishment in Xiaoshan, YOUJIA BIO, with the strong support of the Xiaoshan District Committee, the district government, and various departments, has focused on the research and development of small nucleic acid innovative drugs and built a proprietary intellectual property platform.SEQUADNucleic Acid Drug Development Platform, continuously advancing the research and development of multiple innovative drug pipelines, achieving key breakthroughs in antiviral, metabolic diseases, and oncology fields, successively awarded the qualifications of high-tech enterprise, provincial specialized, refined, novel and small enterprise, and provincial enterprise research institute, steadily moving towards a new stage of industrialization.
The evaluation and selection of the "5213" Industrialization Leadership Project is not only an affirmation of past achievements but also an encouragement for future development. The company will take this as an opportunity to further increase R&D investment, accelerate the industrialization process of the project, and continue to deeply cultivate in the field of nucleic acid drugs. With core innovative results, it aims to reciprocate local support and contribute to the high-quality development of the biopharmaceutical industry in Xiaoshan District.
In the future, YOUJIA BIO will continue to adhereEnable patients to access affordable, efficient, and safe innovative drugs.'s original aspiration, steadily advance technological innovation and the transformation of achievements, and help Xiaoshan build a biomedical industry highland with national influence in China.
[Attachment: Original Text Introduction to Xiaoshan District's "5213" Policy]
The "5213" Project for Innovative and Entrepreneurial Teams in Xiaoshan District is the core support policy of Xiaoshan District to build a talent-strong district and promote science and technology innovation. It focuses on key industries such as biomedicine, artificial intelligence, high-end equipment, and cutting-edge new materials, aiming to attract and cultivate high-level innovative and entrepreneurial teams and establish a full-cycle support system from initial incubation to growth and industrialization leadership.
The policy categorizes projects into two main types: early-stage and industrialization, each with three tiers—Excellence, Leadership, and Rising Star—providing targeted support for enterprise development through R&D subsidies, rent assistance, loan interest discounts, and investment integration.The maximum support amount for high-quality enterprises in the growth stage is 30 million yuan.Fully support the transformation of scientific and technological achievements and industrial implementation, and help enterprises achieve high-quality development.
"5213" PolicyClosely aligned with Xiaoshan's key industry directions, promote the deep integration of the talent chain, innovation chain, industrial chain, and capital chain to build a full life-cycle cultivation system for technology-based enterprises, aiming to create a new pattern of high-quality industrial development in the district.